Celebrating progress and pursuing possibilities. Our discoveries today fuel hope for a healthier breath tomorrow.
Dear Colleagues & Friends,
It’s a great pleasure – as Chairperson of the 7th World Bronchiectasis Conference 2024 - to invite you to join and contribute to the World Bronchiectasis Community meeting planned in Dundee from 4 to 6 July 2024.
Chairman of the 7th WBC
Discover our thoughtfully curated programme, exploring the latest in bronchiectasis research and treatment. A journey of knowledge awaits.
Submit your abstracts, each a unique voice in the expansive world of bronchiectasis. Share your insights and innovations.
Meet our distinguished faculty, pioneers in bronchiectasis research. Their expertise is vital to the conference's discourse.
Register now!
Infections
(including ABP, Pseudomonas, Hemophilus, etc.)
NTM
PCD – Primary Ciliary Dyskinesia
Precision medicine
Respiratory Physiotherapy & Airways Clearance
Treatments and New Drugs
(UK) Chairman
• Professor of Respiratory Research and Honorary Consultant Respiratory
• Physician at the University of Dundee/Ninewells Hospital, Dundee
• Chair of the European Bronchiectasis Network (EMBARC)
• Chair of the British Thoracic Society Science and Research Committee
• Chief Editor of the European Respiratory Journal
(Italy) Co-chair
(Italy) Co-chair
Francesco Blasi, MD, FERS is Professor of Respiratory Medicine in the Department of Pathophysiology and Transplantation at the University of Milan, Italy, as well as Head of Internal Medicine Department and Respiratory Unit of the Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy.
He is also director of the Adult Cystic Fibrosis Center of the Lombardia Regional Referral CF Center and currently a member of the Board of Directors of the University of Milan.
From 2012–2013, he was president of European Respiratory Society (ERS) and from 2016–2017 president of the Italian Respiratory Society (SIP/IRS). From 2017–2018, he was president of the Italian Respiratory Society Research Center (SIP/IRS Centro Ricerche).
Professor Blasi has published more than 350 papers in international journals (WEB of Science (01.12.2018) h-index : 50 Citations: 8620; SCOPUS (01.12.2018) : h-index:53 Citations:10680 ; Google Scholar (1.4.2019): h-index: 70, Citations: 17,668).
His research interests include pneumonia, COPD, bronchiectasis, tuberculosis and NTM infections, cystic fibrosis and lung transplantation
+ Registrations are open
+ Call for abstract is closed
+ Early registration deadline
+ Late breaking abstracts window (for poster only)
Local and Participants Secretariat:
Lena Events and Communication
+44 (0) 207 177 0777
Organising and Sponsors Secretariat:
PUBLI CREATIONS S.A.M.
+377 97 97 35 55
wbc@lena.events
Receive updates and news about the congress directly into your inbox
Copyright ©2023 7th WBC  |  All Rights Reserved  |  Powered by Lenagroup
Dear Colleagues & Friends,
It’s a great pleasure – as Chairperson of the 7th World Bronchiectasis Conference 2024 - to invite you to join and contribute to the World Bronchiectasis Community meeting planned in Dundee from 4 to 6 July 2024.
The last years have been amazing for our international community.
Bronchiectasis has emerged from its history as a neglected condition to now being a dynamic field experiencing rapid progress. New translational science is helping to reveal the physiopathological mechanisms behind the disease and identify new targets. EMBARC and National Registries have contributed to describing the epidemiology, providing us with precious insights into the natural history of the disease, its comorbidities, and its current management approaches across different countries. Together we have set key priorities for research to improve the quality of life of patients.
The COVID-19 pandemic and the past several years of scientific progress have clearly placed respiratory tract infections at the centre of public health, clinical practice, and scientific debate, helping us to provide new instruments to prevent and treat exacerbations and comorbidities.
Our Multidisciplinary teams, including specialist nurses, physiotherapists and other healthcare professionals are improving the patient journey, in some countries where resources are being devoted to bronchiectasis, while in many countries we still have a long way to go to succeed in being included in the delivery of healthcare for bronchiectasis patients.
After years of repurposing therapies from COPD and cystic fibrosis, new therapies are in development specifically for bronchiectasis and therapeutic breakthroughs feel closer than ever.
The omics revolution is now helping us in starting to breakthrough the heterogeneity of the disease as well as to understand the causes behind the symptoms.
Bronchiectasis stands on the threshold of a new age of exciting science and therapeutic development.
With this exciting context, I invite you to participate and contribute to the next World Bronchiectasis Conference and work together with us to create a better future for our patients with bronchiectasis.
Yours Sincerely,
James D. Chalmers      Â
Chairman of the 7th WBC
